Yubo International Biotech Ltd (YBGJ) Executive Compensation
Yubo International Biotech Ltd (YBGJ) is a publicly traded company on the OTC, categorized under SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: YBGJ
CIK: 895464
Exchange: OTC
SIC 3845: Electromedical & Electrotherapeutic Apparatus
Fiscal Year End: 12/31
State: NY
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
HCL,PLLC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerZhenhui Huang
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001640334-26-001352 | View SEC Doc Filr Page |
| ARS | 2026-06-12 | 2025-12-31 | ARS | 0001640334-26-001040 | View SEC Doc Filr Page |
| DEF 14C | 2026-06-12 | 2026-06-10 | DEF 14C | 0001640334-26-001039 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001640334-26-000912 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | FORM 10-K | 0001640334-26-000598 | View SEC Doc Filr Page |
| 8-K | 2026-01-16 | 2026-01-13 | FORM 8-K | 0001640334-26-000105 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | FORM 10-Q | 0001640334-25-002083 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | FORM 10-Q | 0001640334-25-001439 | View SEC Doc Filr Page |
| 4 | 2025-07-25 | 2025-07-23 | FORM 4 | 0001640334-25-001324 | View SEC Doc Filr Page |
| 4 | 2025-07-25 | 2025-07-23 | FORM 4 | 0001640334-25-001323 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-07-25 | — | SCHEDULE 13D/A Filing | 0001640334-25-001322 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-07-25 | — | SCHEDULE 13D/A Filing | 0001640334-25-001321 | View SEC Doc Filr Page |
| 8-K | 2025-07-25 | 2025-07-23 | FORM 8-K | 0001640334-25-001318 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-06-03 | — | SCHEDULE 13G Filing | 0001640334-25-000984 | View SEC Doc Filr Page |
| 4 | 2025-06-03 | 2024-01-25 | FORM 4 | 0001640334-25-000982 | View SEC Doc Filr Page |
| 4 | 2025-06-02 | 2024-07-15 | FORM 4 | 0001640334-25-000959 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | FORM 10-Q | 0001640334-25-000837 | View SEC Doc Filr Page |
| 3 | 2025-05-05 | 2025-05-05 | FORM 3 | 0001640334-25-000741 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-04-25 | — | SCHEDULE 13D/A Filing | 0001640334-25-000688 | View SEC Doc Filr Page |
| DEF 14C | 2025-04-14 | 2025-04-08 | DEF 14C | 0001640334-25-000621 | View SEC Doc Filr Page |
| PRE 14C | 2025-04-02 | 2025-04-01 | PRE 14C | 0001640334-25-000580 | View SEC Doc Filr Page |
| 10-K | 2025-03-31 | 2024-12-31 | FORM 10-K | 0001640334-25-000547 | View SEC Doc Filr Page |
| 8-K/A | 2025-01-10 | 2024-12-30 | FORM 8-K/A | 0001640334-25-000050 | View SEC Doc Filr Page |
| 8-K | 2025-01-06 | 2024-12-26 | FORM 8-K | 0001640334-25-000025 | View SEC Doc Filr Page |
| 10-Q | 2024-11-13 | 2024-09-30 | FORM 10-Q | 0001640334-24-001693 | View SEC Doc Filr Page |